PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
Running, not enrolling · Phase 4
Conditions studied: Surgical Site Infection
In brief
The purpose of this study is to see whether applying povidone iodine (PVI) to the noses of patients undergoing lower extremity (leg, ankle, or foot) orthopedic fixation procedures of high-energy lower extremity fractures (HELEF) will decrease the patients' risk of surgical site infections (SSI), particularly those caused by Staphylococcus aureus.
Key facts
- Study ID
- NCT05763602
- Run by
- Loreen Herwaldt
- People needed
- 2000
- Starts
- 2022-09-15
- Expected to finish
- 2026-05-31
- Last updated by the study team
- 2026-02-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age > 18 years of age.
- Is undergoing one or more procedures to address the included fractures listed below for one or more (at least one) HELEF at high-risk for SSI:
- Open tibia fractures
- Open femur fractures
- Open or closed tibial plateau fractures
- Open or closed tibial pilon fractures
- Open or closed calcaneus fractures
- Open or closed talus fractures
- Open or closed foot fractures of any bone EXCEPT the toes
- Open fibula fractures
- Open rotational ankle fractures (malleoli)
- Open or closed leg fractures associated with compartment syndrome
- Examples of included procedures:
- Excisional debridement of open fracture, femur and/or tibia
- Intramedullary nail, tibia (open injury)
- Intramedullary nail, femur (open injury)
- Open reduction Pilon/Plafond fracture
- Open reduction tibial plateau fracture
- Open reduction calcaneal fracture
- Open reduction Lisfranc/metatarsal associated with crush injury
- Open reduction talus
- External fixation, lower extremity tibia or femur associated with open fracture or compartment syndrome
- Fasciotomy, lower extremity for compartment syndrome related to femur, tibia, or foot fracture
- Lower extremity amputation related to HELEF
You may not qualify if…
- Documented or verbalized sensitivity or allergy to iodine or iodine-based contrast.
- Known pregnancy in women.
- Active bacterial infection at the HELEF site.
- Incarcerated persons.
- Persons who cannot follow up at the participating site (e.g., people who are homeless at the time of the injury or people with intellectual challenges who lack the social support for follow up visits).
- Patients with facial fractures or other conditions that preclude nasal swabbing.
- Patients who do not speak English or Spanish.
Where it is running
- Emory University — Atlanta, Georgia, United States
- University of Indiana — Indianapolis, Indiana, United States
- University of Iowa — Iowa City, Iowa, United States
- Washington University — St Louis, Missouri, United States
- University of Texas Southwestern — Dallas, Texas, United States
- University of Utah — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.